Arterial Disease
14
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.1%
1 terminated out of 14 trials
87.5%
+1.0% vs benchmark
7%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation
Correlation Between LR-ACT and Anti Xa Activity During Endovascular Surgery Procedures. AXAES (Anti Xa vs ACT-LR in Endovascular Surgery)
Dynamic Arterial Elastance: an Indirect Marker of the Critical Capillary Pressure at the Microcirculatory Level
Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease
ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.
Measuring the ACT During Non-cardiac Arterial Procedures.
The Feasibility of Multispectral Optoacoustic Tomography in Different Diseases
PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent
Promus PREMIER Below The Knee Registry
Relationship Between Digital Vascular Function Measured by EndoPAT® in elderlY Patients and Arterial Stiffness
Inguinal Hernia and Arterial Disease
Vital USA SpO2 Accuracy Comparison to Arterial Blood CO-Oximetry
Efficacy Between Different Two Self-Expanding Nitinol Stents For The Atherosclerotic Femoro-Popliteal Arterial Disease